Skip to main content
Diagnostics logoLink to Diagnostics
. 2025 Aug 26;15(17):2152. doi: 10.3390/diagnostics15172152

Reply to Lian, M.; Zhang, C. Comment on “Mureșan et al. Prognostic Nutritional Index, Controlling Nutritional Status (CONUT) Score, and Inflammatory Biomarkers as Predictors of Deep Vein Thrombosis, Acute Pulmonary Embolism, and Mortality in COVID-19 Patients. Diagnostics 2022, 12, 2757”

Adrian Vasile Mureșan 1,2, Ioana Hălmaciu 3, Emil-Marian Arbănași 1,2,4,*, Réka Kaller 1,2, Eliza-Mihaela Arbănași 4, Ovidiu Aurelian Budișcă 5, Răzvan Marian Melinte 6,7, Vlad Vunvulea 8, Rareș Cristian Filep 3, Lucian Mărginean 3, Bogdan Andrei Suciu 8, Klara Brînzaniuc 8, Raluca Niculescu 9, Eliza Russu 1,2
Editor: Aw Tar-Choon
PMCID: PMC12428748  PMID: 40941641

We appreciate the insightful commentary by Mengyi Lian and Chengwei Zhang regarding our manuscript “Prognostic Nutritional Index, Controlling Nutritional Status (CONUT) Score, and Inflammatory Biomarkers as Predictors of Deep Vein Thrombosis, Acute Pulmonary Embolism, and Mortality in COVID-19 Patients” [1,2]. In our research, we found that higher admission levels of inflammatory biomarkers and CONUT Score, along with lower PNI values, were linked to a greater risk of deep vein thrombosis (DVT), acute pulmonary embolism (APE), and mortality among COVID-19 patients [1].

We appreciate Mengyi Lian and Chengwei Zhang for their insightful observations and completely concur with their point that it is unreasonable for all eight variables to become independent risk factors simultaneously [2]. Regrettably, due to a technical oversight, the phrase “multivariate analysis” mistakenly appeared in the final version of the manuscript. Furthermore, the results in Table 5 of the original paper [1], as noted by Mengyi Lian and Chengwei Zhang, actually reflect univariate analysis [2].

In the present response, we include a table illustrating the multivariate analysis in which we propose three adjustment models as follows: Model 1 (age and sex), Model 2 (age, sex, chronic heart failure, atrial fibrillation, myocardial infarction, chronic kidney disease, peripheral arterial disease, malignancy, tobacco, obesity, and dyslipidemia), and Model 3 (age, sex, chronic heart failure, atrial fibrillation, myocardial infarction, chronic kidney disease, peripheral arterial disease, malignancy, tobacco, obesity, dyslipidemia, and all other biomarkers). As demonstrated in Table 1, the association identified in the univariate analysis presented in our manuscript is further corroborated after adjusting for Models 1 and 2. Nevertheless, as articulated by Mengyi Lian and Chengwei Zhan, when accounting for additional biomarkers, the systemic inflammatory index (SII), the aggregate index of systemic inflammation (AISI), and the prognostic nutritional index (PNI) forfeit their predictive capacity concerning DVT. Furthermore, the monocyte to lymphocyte ratio (MLR), platelet to lymphocyte ratio (PLR), SII, systemic inflammation response index (SIRI), and PNI likewise relinquish their predictive significance regarding the risk of APE, while MLR, SIRI, and AISI similarly lose their predictive relevance concerning mortality.

Table 1.

Multivariate analysis of predictors for DVT, APE, and mortality during the in-hospital stay.

Biomarkers Deep Vein Thrombosis Acute Pulmonary Embolism Mortality
OR 95% CI p Value OR 95% CI p Value OR 95% CI p Value
high-MLR Model 1 11.51 7.87–16.82 <0.001 6.30 3.55–11.16 <0.001 6.80 4.57–10.13 <0.001
Model 2 10.32 6.96–15.29 <0.001 4.33 2.33–8.03 <0.001 5.73 3.80–8.66 <0.001
Model 3 4.42 7.87–16.82 <0.001 1.66 0.70–3.96 0.248 1.83 0.95–3.53 0.070
high-NLR Model 1 11.72 8.01–17.18 <0.001 8.98 5.13–15.75 <0.001 13.01 8.23–20.51 <0.001
Model 2 10.23 6.88–15.18 <0.001 7.70 4.14–14.32 <0.001 11.73 7.31–18.85 <0.001
Model 3 2.40 1.31–4.42 0.005 3.27 1.32–8.12 0.011 2.56 1.19–5.50 0.016
high-PLR Model 1 8.53 5.92–12.29 <0.001 4.57 2.54–8.24 <0.001 10.99 7.29–16.55 <0.001
Model 2 7.85 5.39–11.43 <0.001 4.01 2.13–7.55 <0.001 10.82 7.02–16.69 <0.001
Model 3 2.24 1.21–4.17 0.011 1.06 0.35–3.22 0.917 3.02 1.53–5.96 0.001
high-SII Model 1 9.24 6.40–13.87 <0.001 5.07 2.78–9.23 <0.001 11.34 7.30–17.61 <0.001
Model 2 8.68 5.81–12.97 <0.001 4.45 2.32–8.52 <0.001 11.26 7.07–17.91 <0.001
Model 3 1.71 0.75–3.91 0.201 0.67 0.17–2.69 0.579 3.07 1.18–7.97 0.021
high-SIRI Model 1 9.41 6.42–13.81 <0.001 5.66 3.20–10.01 <0.001 6.58 4.41–9.81 <0.001
Model 2 8.39 5.62–12.53 <0.001 4.39 2.39–8.08 <0.001 5.81 3.82–8.81 <0.001
Model 3 2.45 1.09–5.52 0.030 1.08 0.31–3.82 0.900 1.61 0.63–4.12 0.320
high-AISI Model 1 6.26 4.39–8.93 <0.001 6.02 3.50–10.28 <0.001 6.21 4.17–9.25 <0.001
Model 2 5.48 3.81–7.92 <0.001 5.28 2.92–9.54 <0.001 5.60 3.70–8.47 <0.001
Model 3 0.51 0.23–1.15 0.107 3.36 1.03–11.01 0.045 0.70 0.26–1.86 0.476
high-PNI Model 1 5.43 3.81–7.76 <0.001 12.75 7.07–22.97 <0.001 27.92 16.99–45.89 <0.001
Model 2 5.00 3.47–7.21 <0.001 11.58 6.11–21.93 <0.001 31.16 18.34–52.95 <0.001
Model 3 1.08 0.63–1.87 0.763 0.61 0.18–2.04 0.417 6.84 3.00–15.59 <0.001
high-CONUT Score Model 1 9.72 6.76–13.97 <0.001 32.19 16.76–61.82 <0.001 41.66 21.95–79.04 <0.001
Model 2 9.16 6.29–13.33 <0.001 34.18 16.24–71.86 <0.001 44.54 22.91–86.61 <0.001
Model 3 8.24 4.69–14.47 <0.001 44.81 12.28–163.39 <0.001 10.92 4.24–28.11 <0.001

Model 1: age and sex. Model 2: age, sex, chronic heart failure, atrial fibrillation, myocardial infarction, chronic kidney disease, peripheral arterial disease, malignancy, tobacco, obesity, and dyslipidemia. Model 3: age, sex, chronic heart failure, atrial fibrillation, myocardial infarction, chronic kidney disease, peripheral arterial disease, malignancy, tobacco, obesity, dyslipidemia, and other biomarkers.

The authors wish to replace the term “multivariate” with “univariate” in the original publication [1]. However, within the current manuscript, we present the multivariate analysis. The authors sincerely apologize for any inconvenience this may cause and state that the scientific conclusions remain unaffected. It is noteworthy to mention that, despite a technical editing error present in our manuscript, which we shall rectify, the results and conclusions of our study continue to hold validity, even after accounting for the presence of comorbidities, as presented in Table 1. In conclusion, we maintain that, despite the editing error we committed, the results and conclusions of our study remain unchanged, are valid, and do not contain any errors that could adversely affect patient management. Consequently, the initial conclusion derived from the study based on univariate analysis is also reaffirmed in the context of multivariate analysis. In conclusion, we sincerely thank Mengyi Lian and Chengwei Zhang for their keen observations and assistance in identifying a technical editing mistake in our original paper.

Conflicts of Interest

The authors declare no conflict of interest.

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

References

  • 1.Mureșan A.V., Hălmaciu I., Arbănași E.M., Kaller R., Arbănași E.M., Budișcă O.A., Melinte R.M., Vunvulea V., Filep R.C., Mărginean L., et al. Prognostic Nutritional Index, Controlling Nutritional Status (CONUT) Score, and Inflammatory Biomarkers as Predictors of Deep Vein Thrombosis, Acute Pulmonary Embolism, and Mortality in COVID-19 Patients. Diagnostics. 2022;12:2757. doi: 10.3390/diagnostics12112757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Lian M., Zhang C. Comment on Mureșan et al. Prognostic Nutritional Index, Controlling Nutritional Status (CONUT) Score, and Inflammatory Biomarkers as Predictors of Deep Vein Thrombosis, Acute Pulmonary Embolism, and Mortality in COVID-19 Patients. Diagnostics 2022, 12, 2757. Diagnostics. 2025;15:2151. doi: 10.3390/diagnostics15172151. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Diagnostics are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES